WB
Way Biosolutions, Inc.
SEC filingBiotechnology · Cambridge, MA
Amount raised$2Msold at filing
Total offering$2M
Investors in the raise2count reported to the SEC
FiledSep 25, 2026first sale Feb 14, 2025
Form D does not name the investors. If a news report names them, they appear here.
Named in the filing
Huaibin ZhangExecutive Officer, Director
Paul R. MeisterDirector
David R. WaltDirector
Executive officers, directors and promoters as listed on the Form D.